Crossmark

MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population

Crossref DOI link: https://doi.org/10.1016/j.aohep.2024.101488

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Deng, You

Chen, Wenya

Xie, Wen
Funding

Funding for this research was provided by:

Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (D171100003117005)

Beijing Municipal Administration of Hospitals (XXZ04, Z191100007619037)
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-02-20
More Information

This article is maintained by: Elsevier

Article Title: MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2024.101488

Content Type: simple-article

Copyright: © 2024 Published by Elsevier España, S.L.U. on behalf of Fundación Clínica Médica Sur, A.C.